293 related articles for article (PubMed ID: 29070037)
1. Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.
Peeters SA; Engelen L; Buijs J; Chaturvedi N; Fuller JH; Jorsal A; Parving HH; Tarnow L; Theilade S; Rossing P; Schalkwijk CG; Stehouwer CDA
Cardiovasc Diabetol; 2017 Oct; 16(1):139. PubMed ID: 29070037
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Peeters SA; Engelen L; Buijs J; Chaturvedi N; Fuller JH; Schalkwijk CG; Stehouwer CD;
Cardiovasc Diabetol; 2015 Mar; 14():31. PubMed ID: 25848912
[TBL] [Abstract][Full Text] [Related]
3. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
[TBL] [Abstract][Full Text] [Related]
4. Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study.
Vilmi-Kerälä T; Lauhio A; Tervahartiala T; Palomäki O; Uotila J; Sorsa T; Palomäki A
Cardiovasc Diabetol; 2017 Apr; 16(1):49. PubMed ID: 28407807
[TBL] [Abstract][Full Text] [Related]
5. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
6. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
Florys B; Głowińska B; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of MMP-2, MMP-9 and TIMP-1 are not associated with arterial stiffness in subjects with type 2 diabetes mellitus.
Papazafiropoulou A; Perrea D; Moyssakis I; Kokkinos A; Katsilambros N; Tentolouris N
J Diabetes Complications; 2010; 24(1):20-7. PubMed ID: 19062310
[TBL] [Abstract][Full Text] [Related]
8. Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension.
Lacerda L; Faria AP; Fontana V; Moreno H; Sandrim V
Arq Bras Cardiol; 2015 Aug; 105(2):168-75. PubMed ID: 26039662
[TBL] [Abstract][Full Text] [Related]
9. Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Goncalves I; Bengtsson E; Colhoun HM; Shore AC; Palombo C; Natali A; Edsfeldt A; Dunér P; Fredrikson GN; Björkbacka H; Östling G; Aizawa K; Casanova F; Persson M; Gooding K; Strain D; Khan F; Looker HC; Adams F; Belch J; Pinnoli S; Venturi E; Kozakova M; Gan LM; Schnecke V; Nilsson J;
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1723-31. PubMed ID: 25953645
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome.
Michizono K; Umehara F; Hashiguchi T; Arimura K; Matsuura E; Watanabe O; Fujimoto N; Okada Y; Osame M
Neurology; 2001 Mar; 56(6):807-10. PubMed ID: 11274326
[TBL] [Abstract][Full Text] [Related]
11. Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.
Peeters SA; Engelen L; Buijs J; Theilade S; Rossing P; Schalkwijk CG; Stehouwer CDA
J Diabetes Complications; 2018 Mar; 32(3):325-329. PubMed ID: 29395841
[TBL] [Abstract][Full Text] [Related]
12. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
[TBL] [Abstract][Full Text] [Related]
13. Serum MMP-3 and its association with central arterial stiffness among young adults is moderated by smoking and BMI.
Iannarelli NJ; MacNeil AJ; Dempster KS; Wade TJ; O'Leary DD
Physiol Rep; 2021 Jun; 9(11):e14920. PubMed ID: 34110720
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
Maxwell PR; Timms PM; Chandran S; Gordon D
Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.
Yasmin ; McEniery CM; Wallace S; Dakham Z; Pulsalkar P; Maki-Petaja K; Ashby MJ; Cockcroft JR; Wilkinson IB
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):372. PubMed ID: 15556929
[TBL] [Abstract][Full Text] [Related]
17. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
[TBL] [Abstract][Full Text] [Related]
19. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I
Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403
[TBL] [Abstract][Full Text] [Related]
20. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
Beaudeux JL; Giral P; Bruckert E; Bernard M; Foglietti MJ; Chapman MJ
Atherosclerosis; 2003 Jul; 169(1):139-46. PubMed ID: 12860260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
